The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 30, 2021

Filed:

Sep. 12, 2017
Applicant:

The Brigham and Women's Hospital, Inc., Boston, MA (US);

Inventors:

Elena Aikawa, Chestnut Hill, MA (US);

Maximillian Rogers, Boston, MA (US);

Masanori Aikawa, Chestnut Hill, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7105 (2006.01); A61K 45/06 (2006.01); A61K 31/7088 (2006.01); A61P 3/06 (2006.01); C12N 15/113 (2010.01); C12N 15/115 (2010.01); A61K 48/00 (2006.01); A61K 31/47 (2006.01); A61K 31/22 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7105 (2013.01); A61K 31/22 (2013.01); A61K 31/47 (2013.01); A61K 31/7088 (2013.01); A61K 45/06 (2013.01); A61K 48/00 (2013.01); A61P 3/06 (2018.01); C12N 15/115 (2013.01); C12N 15/1137 (2013.01);
Abstract

Provided herein are methods for reducing levels of blood cholesterol, low-density lipoprotein (LDL), and/or the treatment of diseases associated with high cholesterol, hyperlipidemia, dyslipidemia, or high levels of low-density lipoprotein (LDL), wherein the methods comprise administering a DRP1 inhibitor to a subject in need thereof. In certain embodiments, the subject is selected for treatment as described herein when the subject exhibits intolerance to conventional statin therapy. Also contemplated herein are the use of DRP1 inhibitors in the treatment of cancer and inflammatory disease.


Find Patent Forward Citations

Loading…